A Historical Marijuana-Dependence Study Found Some Diagnosed Participants Reported Neither Tolerance Nor Withdrawal

A historical interview study found that some participants with a lifetime marijuana-dependence diagnosis reported neither tolerance nor withdrawal. Those physiological histories distinguished clinical subgroups, rather than serving as interchangeable definitions of the entire disorder.

The study began with diagnosed participants

Structured interviews identified people meeting a lifetime dependence diagnosis for marijuana or other substances. Within each drug group, investigators compared histories involving withdrawal, tolerance without withdrawal, or neither. The design was a clinical-history comparison, not a toxicology test or a controlled cannabis exposure experiment.

Physiological history tracked severity

About thirty percent of the marijuana-dependent group denied both tolerance and withdrawal. Across the substances examined, participants reporting either physiological feature had more severe substance-related problems, with withdrawal histories showing the greatest problem intensity. These associations do not establish that withdrawal itself caused every subsequent difficulty.

The historical criteria set limits on application

The analysis addressed the DSM-IV distinction then under study. It should not be substituted for current diagnostic criteria or used to diagnose someone from a positive drug test. Retrospective interviews also measure reported histories rather than continuous physiological monitoring, and the substance-specific subgroup proportions differed.

Interpreting the evidence

The source helps separate physiological adaptation from a broader clinical classification. Neither the absence of reported withdrawal nor a tolerance history alone establishes all features of an individual's cannabis-related clinical course.

Related reading: selective cannabinoid-related findings in an animal withdrawal model.

Research reference

Schuckit MA; Daeppen JB; Danko GP; et al. (1999). Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. The American journal of psychiatry. doi:10.1176/ajp.156.1.41. Evidence basis: report abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements

The first sample collected after admission to detoxification is not automatically a stable residual-THC baseline. In a study of heavy cannabis users, some participants had smoked only an hour or two before entering treatment. The investigators explicitly cautioned against treating every first-day result as a baseline concentration. Admission and last…

Spread the love

Read Article: Admission Samples in a Residual-THC Study Were Not Automatically Baseline Measurements

An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

A rodent study found pain-related benefits from activating an endogenous adenosine pathway independently of opioid and endocannabinoid mechanisms. Endogenous pain modulation is therefore not automatically evidence of cannabinoid-receptor involvement. The intervention targeted adenosine signaling Researchers increased endogenous adenosine through kinase inhibition and separately tested a selective A3-receptor agonist. Receptor blockade…

Spread the love

Read Article: An Endogenous Pain Pathway Worked Independently of Endocannabinoid Mechanisms in Rodents

Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

A Danish methadone-fatality study reported extensive mixed-drug exposure, including cannabis, and used segmental hair analysis to extend the exposure history beyond blood testing. That additional history was not proof of simultaneous intoxication from every listed substance. The two matrices supplied different information The study examined fatalities with both blood and…

Spread the love

Read Article: Cannabis in a Mixed-Drug Fatality Series: Hair and Blood Answer Different Exposure Questions

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us